Literature DB >> 2889941

Brain copper in Wilson's disease.

J M Walshe, K R Gibbs.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2889941     DOI: 10.1016/s0140-6736(87)92598-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Neuroimaging in Wilson disease.

Authors:  H N van Wassenaer-van Hall
Journal:  Metab Brain Dis       Date:  1997-03       Impact factor: 3.584

2.  Regional cerebral glucose consumption measured by positron emission tomography in patients with Wilson's disease.

Authors:  T Kuwert; H Hefter; D Scholz; M Milz; P Weiss; G Arendt; H Herzog; M Loken; M Hennerici; L E Feinendegen
Journal:  Eur J Nucl Med       Date:  1992

3.  The effect of copper on (3H)-tryptophan metabolism in organ cultures of rat pineal glands.

Authors:  P Parmar; S Daya
Journal:  Metab Brain Dis       Date:  2001-12       Impact factor: 3.584

4.  Dopamine D2 receptor binding and cerebral glucose metabolism recover after D-penicillamine-therapy in Wilson's disease.

Authors:  G Schlaug; H Hefter; B Nebeling; V Engelbrecht; P Weiss; G Stöcklin; R J Seitz
Journal:  J Neurol       Date:  1994-10       Impact factor: 4.849

5.  Relationship between striatal glucose consumption and copper excretion in patients with Wilson's disease treated with D-penicillamine.

Authors:  H Hefter; T Kuwert; H Herzog; G Arendt; W Stremmel; L E Feinendegen
Journal:  J Neurol       Date:  1993-11       Impact factor: 4.849

Review 6.  Different Response Behavior to Therapeutic Approaches in Homozygotic Wilson's Disease Twins with Clinical Phenotypic Variability: Case Report and Literature Review.

Authors:  Sara Samadzadeh; Theodor Kruschel; Max Novak; Michael Kallenbach; Harald Hefter
Journal:  Genes (Basel)       Date:  2022-07-07       Impact factor: 4.141

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.